Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Apimeds Pharmaceuticals USAPUS | Open-market buy | 25/05/13–25/05/14 | 25/05/15 | 27,500 sh2 trades | $1.83avg. | $50,359.2 | No record | |
Jakap KooDirector | Apimeds Pharmaceuticals USAPUS | Open-market buy | 25/05/12 | 25/05/14 | 28,500 sh | $1.99 | $56,715 | +4.6% |
Inscobee10% Owner | Apimeds Pharmaceuticals USAPUS | Open-market buy | 25/05/12 | 25/05/14 | 500,000 sh | $4.00 | $2,000,000 | +33.7% |